Bono rallies telecoms in anti-AIDS wave

Angelina Jolie and Brad Pitt have taken up the plight of children in Africa as their cause, while George Clooney has banded with his father to boost the profile of the conflict in Darfur to rally international attention. Certainly, Hollywood has embraced the continent as a cause worthy of the media limelight it can bring to it. What's more, celebrities are trying to lure in big companies to help them with their causes, including U2 frontman Bono.

The Irish rocker is no stranger to promoting charitable causes, most notably through his efforts to put Third World debt relief on the agenda of finance ministers from some of the world's richest countries, in addition to politicizing his group's concerts. He has since taken that effort further by taking on the cause of AIDS in Africa, and he has succeeded in getting some of the biggest names in the telecommunications industry to back him up.

On Monday U.S. mobile giant Motorola unveiled a series of cell-phone handsets specifically created to help eliminate the epidemic as part of an initiative launched by Bono earlier this year. Specifically, about $18 (10 pounds) from sales of the Red MOTOSLVR series that are sold in Britain will be allocated to the Global Fund to Fight AIDS, in addition to 5 percent of monthly revenue generated by the sales or use of the Red model.

Bono has succeeded not only in getting Motorola to design a handset to cater specifically to the cause, but he has also gotten telecommunications providers and retailers BT Mobile, Carphone Warehouse, Fresh, O2, Orange, Tesco Mobile, T-Mobile, Virgin Mobile and Vodafone to take part in the campaign and donate part of their earnings from the business the Red series generates to the fund as well.

"Red is a 21st century idea. It's an amazing thing that these companies are doing -- lending their creativity and financial firepower to the Global Fund's fight against AIDS in Africa, the greatest health crisis in 600 years. I think doing the Red thing, doing good, will turn out to be good business for them," Bono said in a news release that announced the companies' commitment.

For their part, the telecommunications groups seem only too happy to be offering their time and money to the cause in light of the benefits they bring and the positive publicity that is generated as a result.

"Motorola has been doing business in Africa for more than 30 years, and our support of the Global Fund is one way that we're able to give back to the region. ... We're literally placing in people's hands an opportunity to help find a solution," said Ron Garriques, president of Motorola's mobile-devices unit.

What's more, telecom companies are not the only private corporations that are happy to work with the singer-turned-activist. On Tuesday Bono acted as guest editor of British daily The Independent, which devoted a good chunk of the day's edition to the plight of AIDS in Africa.

"We need to meet you where you are as you shop, as you phone, as you lead your busy, businessy lives. Those of us who campaign on these issues feel we have made a dent on the pop consciousness with Live Aid and 8, Red Nose Day, Comic Relief and Make Poverty History. But we are still losing the battle: 9,000 new infections every day across the developing world," Bono said in Tuesday's editorial page of the newspaper.

Since the Global Fund was set up in 2002 it has received about $9 billion in financial commitments through to 2008 and has approved $5.2 billion in spending on anti-AIDS as well as malaria and tuberculosis projects in more than 130 countries.

Copyright 2006 by United Press International

Related stories:

Strike a pose with Oakley's 'eye-pod'
Looking cool without succumbing to the ever-growing iPod empire is getting easier. While many MP3 fans might swear by the performance of Apple's digital music player, some might want to listen to their tunes without further inflating Steve Jobs' coffers. Oakley might have an answer.
Jump in measles outbreaks worries health officials
(AP) -- The number of measles cases in the U.S. is at its highest level since 1997, and nearly half of those involve children whose parents rejected vaccination, government health officials reported Thursday.
DNA studies show 1 critically endangered grouper species is really 2
Researchers from the University of Hawaii, the Wildlife Conservation Society, Smithsonian Tropical Research Institute, National Marine Fisheries Service and Projecto Meros do Brazil discovered a new species of fish—a grouper that reaches more than six feet in length and can weigh nearly 1,000 pounds. This newly discovered species can be found roaming the tropical reefs of the Eastern Pacific Ocean.
Researcher aim to 'unmask' cancer cells to trigger body's immune system
Cancer cells are deadly traitors, good cells gone bad. They evade the body's defense systems, passing themselves off as organisms that pose no threat.
Biologists find diatom to reduce red tide's toxicity
It's estimated that the red tide algae, Karenia brevis, costs approximately $20 million per bloom in economic damage off the coast of Florida alone. Scientists at the Georgia Institute of Technology have found that a diatom can reduce the levels of the red tide's toxicity to animals and that the same diatom can reduce red tide's toxicity to other algae as well. If scientists can learn to use this process to reduce the toxicity of red tide, they could reduce the vast amount of economic damage done to the seafood and tourism industries. The research appears as articles in press for the Web sites of the journals Harmful Algae and the Proceedings of the Royal Society of London B.
Synthetic moleculues could add spice to fight against cancer
Turning up the heat on the red tomato during processing has the potential to give the popular garden staple added disease-fighting power, Ohio State University research suggests.
Stem cells can be used to create limitless blood supplies: paper
Scientists from a US firm claim to have created a large number of red blood cells from human embryonic stem cells, opening up the prospect of having a limitless supply of blood for transfusions.
Researcher develops novel method to grow human embryonic stem cells
(PhysOrg.com) -- The majority of researchers working with human embryonic stem cells (hESCs) – cells which produce any type of specialized adult cells in the human body – use animal-based materials for culturing the cells. But because these materials are animal-based, they could transmit viruses and other pathogens to the hESCs, making the cells unsuitable for medical use.

News discussion:

Medicine & Health news